Division of Cardiology, Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
Heart and Vascular Theme, Karolinska University Hospital, Stockholm, Sweden.
Catheter Cardiovasc Interv. 2021 Feb 15;97(3):386-392. doi: 10.1002/ccd.28760. Epub 2020 Feb 7.
Conflicting evidence exists concerning the cardioprotective efficacy of remote ischemic conditioning as an adjunct to primary percutaneous intervention (PCI) in ST-elevation myocardial infarction (STEMI) and data on long-term outcomes are scarce. We evaluated final infarct size by cardiac magnetic resonance (CMR) performed 6 months after anterior STEMI treated with remote ischemic conditioning and clinical outcomes up to 3 years after the event.
One hundred and fifteen patients with anterior STEMI were randomized to remote ischemic per-postconditioning (RIperpostC) or sham procedure as adjunct to primary PCI. The primary outcome was myocardial salvage index (MSI) on CMR 6 months after the event. Secondary outcomes were absolute infarct size, left ventricular function, cardiac mortality, major adverse cardiac and cerebrovascular events (MACCE-composite of all-cause mortality, myocardial infarction, readmission for heart failure, ischemic stroke, and target lesion revascularization) and all the individual components of MACCE.
There was no difference in MSI or left ventricular function between the RIperpostC and the control group after 6 months. Nor did clinical outcomes at 6 months or 3 years differ between the groups.
RIperpostC as an adjunct to PCI in anterior STEMI did not result in better MSI or left ventricular function 6 months after the event. Furthermore, clinical outcomes at 6 months and 3 years were not altered.
关于远程缺血预处理作为经皮冠状动脉介入治疗(PCI)辅助治疗 ST 段抬高型心肌梗死(STEMI)的心脏保护效果存在相互矛盾的证据,并且关于长期结果的数据也很少。我们通过心脏磁共振(CMR)评估了前壁 STEMI 患者接受远程缺血预处理后的最终梗死面积,并评估了事件发生后 3 年内的临床结果。
115 例前壁 STEMI 患者被随机分为远程缺血后处理(RIpostC)组或假手术组,作为 PCI 的辅助治疗。主要终点是事件发生后 6 个月时的心肌挽救指数(MSI)。次要终点是绝对梗死面积、左心室功能、心脏死亡率、主要不良心脏和脑血管事件(MACCE-全因死亡率、心肌梗死、心力衰竭再入院、缺血性卒中和靶病变血运重建的复合终点)和 MACCE 的所有单个组成部分。
在 6 个月时,RIpostC 组和对照组之间的 MSI 或左心室功能没有差异。在 6 个月或 3 年时,两组之间的临床结果也没有差异。
在前壁 STEMI 患者中,PCI 辅助应用 RIpostC 并不能在事件发生后 6 个月时改善 MSI 或左心室功能。此外,6 个月和 3 年时的临床结果也没有改变。